Aida Pharmaceuticals, Inc. Company Review & Valuation
AIDA
OTC Markets
Latest Price
0.00USD
About Aida Pharmaceuticals, Inc.
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China.
It offers antibiotics, cardiovascular, and anti-cancer drugs.
The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment.
The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers.
Aida Pharmaceuticals, Inc.
was founded in 1999 and is headquartered in Hangzhou, China.
Industry
Business Services
HQ Location
Hangzhou, China
Stock Price
Price data not available for Aida Pharmaceuticals, Inc..
Performance
Please login or create a free account to view the contents of this section.
Valuation
Please login or create a free account to view the contents of this section.
Financial Reports
Please login or create a free account to view the contents of this section.